National Amphetamine-Type Stimulant Strategy 2008-2011
Ministerial Council on Drug Strategy; Commonwealth of Australia
Country Resources
Substance Abuse Strategies and Plans
Australia
31 December 2008
Policy document
Print
This translation feature uses a third-party service. Please be advised that the machine-translated content may not be accurate. Translation only applies to this page and is not available for downloaded files or external links.
This item may no longer be in force or up to date. Please check to see if a newer version of this item is available. This item record has been included for historical and reference purposes only.
Description
The National Amphetamine-Type Stimulant (ATS) Strategy 2008-2011 is informed bythe research literature, scientific evidence, a nationwide consultation process and written
submissions from key stakeholders around Australia.
The aim of the ATS Strategy is to:
Reduce the availability and demand for illicit amphetamine-type stimulants and prevent
use and harms across the Australian community
Content
WHO collates and provides external links to resources focusing on mental health, disability, general health, human rights and development but does not specifically endorse particular laws, policies, plans or other documents from countries or organisations. WHO also does not warrant that the information in this record is correct or refers to the most up-to-date version. Please read the site disclaimer for further details. If this record contains an error or is outdated, please notify us.
